首页> 外文OA文献 >ET-51 * COMBINED THERAPY WITH A NOVEL CXCR4 ANTAGONIST AND AN ANTI-VEGF ANTIBODY IMPAIRS THE GROWTH OF GLIOMAS

【2h】

ET-51 * COMBINED THERAPY WITH A NOVEL CXCR4 ANTAGONIST AND AN ANTI-VEGF ANTIBODY IMPAIRS THE GROWTH OF GLIOMAS

机译：ET-51 *用新型CXCR4拮抗剂和抗VEGF抗体的组合治疗损害了胶质瘤的生长

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Y. Sarfraz; F. M. Alotaibi; V. Ortenzi; A. T. Tayyib; G. J. Douglas; E. Chevalier; B. Romagnoli; G. Tuffin; J.-P. Gagner; D. Zagzag;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies. [J] . Buchner M, Brantner P, Stickel N, British Journal of Haematology . 2010,第2期

机译：在慢性淋巴细胞性白血病中，微环境有损于被动和主动免疫疗法-CXCR4拮抗剂可作为单克隆抗体的潜在佐剂。
2. The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia – CXCR4 antagonists as potential adjuvants for monoclonal antibodies [J] . Maike Buchner, Philipp Brantner, Natalie Stickel, British Journal of Haematology . 2010,第2期

机译：在慢性淋巴细胞性白血病中，微环境差异性地削弱了被动和主动免疫疗法– CXCR4拮抗剂可作为单克隆抗体的潜在佐剂
3. Enhanced suppression of melanoma tumor growth and metastasis by combined therapy with anti-VEGF receptor and anti-TYRP-1/gp75 monoclonal antibodies. [J] . Patel D, Bassi R, Hooper AT Anticancer Research: International Journal of Cancer Research and Treatment . 2008,第5Appa期

机译：通过与抗VEGF受体和抗TYRP-1 / gp75单克隆抗体联合治疗，增强了对黑色素瘤肿瘤生长和转移的抑制作用。
4. Pre-Clinical Development of CXCR4 Antagonist Antibody for Cancer Immunotherapy [C] . Dmitry Poteryaev, Alexer Piskunov, Maria Aksenova, International Molecular Medicine Tri-Conference. . 2016

机译：CXCR4拮抗剂抗体癌症免疫疗法的临床开发
5. Efficacy of Combined 5-Fluorouracil and Photodynamic Therapy in Glioma Spheroids [D] . Singh, Karanjit 2018

机译：5-氟尿嘧啶联合光动力疗法治疗脑胶质瘤球体的疗效
6. ET-51COMBINED THERAPY WITH A NOVEL CXCR4 ANTAGONIST AND AN ANTI-VEGF ANTIBODY IMPAIRS THE GROWTH OF GLIOMAS [O] . Yasmeen Sarfraz, Fawaz M. Alotaibi, Valerio Ortenzi, 2014

机译：ET-51与新型CXCR4拮抗剂和抗VEGF抗体联合治疗可减轻胶质瘤的生长
7. Combined use of Anti-VEGF and Anti-EGFR Monoclonal Antibodies with Photodynamic Therapy Suppresses Tumor Growth in an In vivo Tumor Model [O] . Ramaswamy Bhuvaneswari 2013

机译：结合使用抗VEGF和抗EGFR单克隆抗体与光动力疗法抑制了体内肿瘤模型中的肿瘤生长

ET-51 * COMBINED THERAPY WITH A NOVEL CXCR4 ANTAGONIST AND AN ANTI-VEGF ANTIBODY IMPAIRS THE GROWTH OF GLIOMAS

著录项

引文网络

相似文献

相关主题

期刊订阅